F. Raja

1.6k total citations · 1 hit paper
12 papers, 1.2k citations indexed

About

F. Raja is a scholar working on Reproductive Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F. Raja has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Reproductive Medicine, 5 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F. Raja's work include Ovarian cancer diagnosis and treatment (7 papers), Intraperitoneal and Appendiceal Malignancies (5 papers) and Renal cell carcinoma treatment (3 papers). F. Raja is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Intraperitoneal and Appendiceal Malignancies (5 papers) and Renal cell carcinoma treatment (3 papers). F. Raja collaborates with scholars based in United Kingdom, United States and Italy. F. Raja's co-authors include Jonathan A. Ledermann, Antonio González-Martı́n, Christina Fotopoulou, Nicoletta Colombo, Cristiana Sessa, Neha Chopra, N. Colombo, C. Sessa, Mahesh Parmar and Hal W. Hirte and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and American Journal of Clinical Pathology.

In The Last Decade

F. Raja

8 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2013 791 citations Jonathan A. Ledermann, F. Raja et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Raja United Kingdom	6	781	497	290	230	207	12	1.2k
Vanda Salutari Italy	23	722 0.9×	555 1.1×	333 1.1×	291 1.3×	412 2.0×	110	1.5k
Alla Lisyanskaya Russia	15	550 0.7×	447 0.9×	233 0.8×	303 1.3×	139 0.7×	49	1.1k
Hidekatsu Nakai Japan	21	667 0.9×	445 0.9×	323 1.1×	191 0.8×	418 2.0×	75	1.3k
J. J. Kavanagh United States	17	545 0.7×	396 0.8×	308 1.1×	303 1.3×	232 1.1×	50	1.2k
Marilena Di Napoli Italy	16	374 0.5×	433 0.9×	331 1.1×	119 0.5×	210 1.0×	64	1.0k
Eizo Kimura Japan	11	754 1.0×	370 0.7×	206 0.7×	394 1.7×	290 1.4×	20	1.1k
Maria Ornella Nicoletto Italy	18	445 0.6×	581 1.2×	496 1.7×	214 0.9×	100 0.5×	54	1.3k
Gianni Amunni Italy	20	449 0.6×	358 0.7×	261 0.9×	188 0.8×	526 2.5×	55	1.2k
Rosalind Glasspool United Kingdom	25	753 1.0×	722 1.5×	842 2.9×	181 0.8×	375 1.8×	86	1.9k
E. A. Eisenhauer Canada	16	504 0.6×	404 0.8×	357 1.2×	313 1.4×	241 1.2×	31	1.2k

Countries citing papers authored by F. Raja

Since Specialization

Citations

This map shows the geographic impact of F. Raja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Raja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Raja more than expected).

Fields of papers citing papers by F. Raja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Raja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Raja. The network helps show where F. Raja may publish in the future.

Co-authorship network of co-authors of F. Raja

This figure shows the co-authorship network connecting the top 25 collaborators of F. Raja. A scholar is included among the top collaborators of F. Raja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Raja. F. Raja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Fessas, Petros, et al.. (2024). 145P Impact of immunotherapy addition to dose density of neoadjuvant chemotherapy for triple-negative breast cancer: A retrospective, real-world study from multiple centres in London (UK). ESMO Open. 9. 103132–103132.

Raja, F., et al.. (2024). Why You've Got Mail: Evaluating Inbox Privacy Implications of Email Marketing Practices in Online Apps and Services. 221–232.

Raja, F., et al.. (2024). Diffuse Large B-cell Lymphoma (DLBCL) involving the Uterine Corpus presenting with Abnormal Uterine Bleeding: A Rare Case Report. American Journal of Clinical Pathology. 162(Supplement_1). S61–S62.

Joharatnam‐Hogan, Nalinie, Daniel Hochhauser, Hannah Rush, et al.. (2020). LBA83 Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: A multi-centre North London experience. Annals of Oncology. 31. S1209–S1209. 1 indexed citations

Ledermann, Jonathan A., F. Raja, Christina Fotopoulou, et al.. (2018). Corrections to “Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”. Annals of Oncology. 29. iv259–iv259. 104 indexed citations

Jenkinson, S. Rhiannon, et al.. (2016). An audit into granulocyte-colony stimulating factor (G-CSF) primary prophylaxis for early breast cancer chemotherapy at the North Middlesex University Hospital (NMUH). Clinical Oncology. 28. S12–S13.

McNeish, Iain A., JA Ledermann, Lisa M. James, et al.. (2014). A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer. Annals of Oncology. 25(10). 1988–1995. 64 indexed citations

Ledermann, Jonathan A., F. Raja, Christina Fotopoulou, et al.. (2013). Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 24(Suppl 4). vi24–vi32. 791 indexed citations breakdown →

Raja, F., Nicholas Counsell, Nicoletta Colombo, et al.. (2013). Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data. Annals of Oncology. 24(12). 3028–3034. 63 indexed citations

10.

Raja, F., Neha Chopra, & Jonathan A. Ledermann. (2012). Optimal first-line treatment in ovarian cancer. Annals of Oncology. 23. x118–x127. 104 indexed citations

11.

Raja, F., Nicholas Counsell, Nicoletta Colombo, et al.. (2012). Platinum Combination Chemotherapy Versus Platinum Monotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis of Randomised Trials Using Individual Patient Data (IPD). Annals of Oncology. 23. ix324–ix324. 4 indexed citations

12.

Raja, F., Clare Griffin, W. Qian, et al.. (2011). Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer. British Journal of Cancer. 105(7). 884–889. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact